U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07205549) titled 'Utilization of Musculoskeletal Ultrasound to Detect Subclinical Findings in IBD Patients' on Sept. 17.
Brief Summary: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, frequently presents with musculoskeletal extraintestinal manifestations (EIMs), such as arthritis and enthesitis, affecting up to 50% of patients. These can be subclinical and are often underestimated by physical examination alone. Musculoskeletal ultrasound (MSK-US) is a sensitive, non-invasive tool for detecting both clinical and subclinical inflammation. Despite its benefits, there is no standardized MSK-US protocol specifically for...